Movement Alert｜Hims & Hers Health Inc. Intraday Rise 5.19% in Regular Trading, FTC Complaint Response Draws Market Focus

Market Focus10-29

On October 29, Hims & Hers Health Inc. rose 5.19% in Regular Trading, trading at $29.55/share, with turnover of $168 million.

The move coincided with continued market attention on the company’s effort to ask a California federal judge to dismiss an FTC complaint alleging that it misled buyers about products and billed for unwanted subscriptions.

Supporting context shows Hims & Hers Health Inc. has also continued expanding its business footprint, including the launch of the Hers women’s health platform in Australia following the rebranding of its existing Juniper service, as well as the rollout of a twice-weekly subcutaneous testosterone-boosting injection, underscoring ongoing international and product expansion even as the legal process remains in focus.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment